Applied DNA Sciences, Inc. (APDN)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 2.7900 |
| Open | 2.7400 |
| Bid | 2.5700 x 100 |
| Ask | 2.7100 x 100 |
| Day's Range | 2.5001 - 2.7400 |
| 52 Week Range | 2.5000 - 37.2000 |
| Volume | |
| Avg. Volume | 58,408 |
| Market Cap | 2.472M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -17.6300 |
| Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
ACCESSWIREInstitute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
STONY BROOK, NY / ACCESSWIRE / May 13, 2024 /Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, and the Institute of Hematology and Blood Transfusion (ÚHKT/IHBT) today announced that an abstract relating ...
Simply Wall St.Applied DNA Sciences Second Quarter 2024 Earnings: Misses Expectations
Applied DNA Sciences ( NASDAQ:APDN ) Second Quarter 2024 Results Key Financial Results Revenue: US$929.6k (down 79...
ZacksApplied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -15.43% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.